What is the typical starting dose of Prozac (fluoxetine) for a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Prozac (Fluoxetine)

Start fluoxetine at 20 mg once daily in the morning for most adult patients with depression. 1

Standard Adult Dosing for Depression

  • The FDA-approved starting dose is 20 mg/day administered in the morning, which is sufficient to obtain a satisfactory response in major depressive disorder in most cases. 1
  • This 20 mg/day dose has been shown to maintain efficacy for up to 38 weeks in controlled trials. 1
  • The maximum dose should not exceed 80 mg/day. 1

Alternative Lower Starting Dose Strategy

Consider starting at 10 mg daily (or even 10 mg every other morning) in patients prone to anxiety or activation side effects. 2

  • The American Academy of Family Physicians recommends 10 mg every other morning or 10 mg daily as an alternative starting approach, particularly when tolerability is a concern. 2
  • This lower-dose strategy is especially useful because 28% of patients cannot tolerate the full 20 mg dose, with half of these patients benefiting from lower doses. 3
  • Patients with concurrent panic disorder are particularly intolerant of the standard 20 mg dose and may require starting at 5-10 mg daily. 3

Pediatric Dosing (Children and Adolescents)

  • Start with 10 mg/day in adolescents and higher-weight children, then increase to 20 mg/day after 1-2 weeks. 1
  • For lower-weight children, initiate at 10 mg/day and consider this as both the starting and potentially the target dose due to higher plasma levels in this population. 1

Special Population Adjustments

Reduce the starting dose by approximately 50% in elderly patients. 2

  • The American Academy of Family Physicians recommends lower or less frequent dosing in elderly patients due to significantly greater risk of adverse drug reactions. 2
  • Patients with hepatic impairment require lower or less frequent dosing. 1

CYP2D6 poor metabolizers should start at 10 mg daily with cautious titration due to 3.9 to 11.5-fold higher fluoxetine levels and significantly increased toxicity risk, including FDA warnings about QT prolongation. 2

Condition-Specific Dosing Variations

Obsessive-Compulsive Disorder (OCD)

  • Start at 20 mg/day in adults, though doses of 60 mg/day are typically needed for full therapeutic effect. 1
  • Higher doses are generally necessary for OCD compared to depression. 2

Bulimia Nervosa

  • The target dose is 60 mg/day, though it may be advisable to titrate up to this dose over several days rather than starting at this level. 1

Critical Timing and Pharmacokinetic Considerations

  • Fluoxetine should be taken in the morning because it is activating and may cause insomnia if taken later in the day. 2
  • The full therapeutic effect may be delayed until 4-5 weeks of treatment or longer due to fluoxetine's exceptionally long half-life (1-3 days for parent compound, 4-16 days for active metabolite norfluoxetine). 2, 1
  • Side effects may not manifest for several weeks after starting treatment, as steady-state conditions are reached only after approximately 5-7 weeks. 2

Common Pitfalls to Avoid

  • Do not increase the dose at 1-2 week intervals; wait 3-4 weeks between dose adjustments due to the long half-life. 2
  • Common early adverse events (nausea, insomnia, nervousness, somnolence) resolve in the majority of patients and become significantly less frequent with continued treatment. 4
  • If unexpected adverse effects develop at standard doses, consider CYP2D6 testing before escalating doses further. 2

References

Guideline

Management of Increased Anxiety After Fluoxetine Dose Increase

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Use of low-dose fluoxetine in major depression and panic disorder.

The Journal of clinical psychiatry, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.